
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic alterations mediated by STAT3 promotes drug persistence in CML
Sweta B. Patel, Travis Nemkov, Davide Stefanoni, et al.
Leukemia (2021) Vol. 35, Iss. 12, pp. 3371-3382
Open Access | Times Cited: 33
Sweta B. Patel, Travis Nemkov, Davide Stefanoni, et al.
Leukemia (2021) Vol. 35, Iss. 12, pp. 3371-3382
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
Rongqing Li, Xueqin Li, Jie Zhao, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 976-998
Open Access | Times Cited: 85
Rongqing Li, Xueqin Li, Jie Zhao, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 976-998
Open Access | Times Cited: 85
Metabolomics in drug research and development: The recent advances in technologies and applications
Huanhuan Pang, Zeping Hu
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3238-3251
Open Access | Times Cited: 31
Huanhuan Pang, Zeping Hu
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3238-3251
Open Access | Times Cited: 31
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 34
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 34
Neurotoxicity of ischemic astrocytes involves STAT3 ‐mediated metabolic switching and depends on glycogen usage
Mina Borbor, Dongpei Yin, Ulf Brockmeier, et al.
Glia (2023) Vol. 71, Iss. 6, pp. 1553-1569
Open Access | Times Cited: 18
Mina Borbor, Dongpei Yin, Ulf Brockmeier, et al.
Glia (2023) Vol. 71, Iss. 6, pp. 1553-1569
Open Access | Times Cited: 18
Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells
Shaowei Qiu, Vipul Sheth, Chengcheng Yan, et al.
Blood (2023) Vol. 142, Iss. 6, pp. 574-588
Open Access | Times Cited: 16
Shaowei Qiu, Vipul Sheth, Chengcheng Yan, et al.
Blood (2023) Vol. 142, Iss. 6, pp. 574-588
Open Access | Times Cited: 16
Deregulated transcription factors in the emerging cancer hallmarks
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin, et al.
Seminars in Cancer Biology (2023) Vol. 98, pp. 31-50
Closed Access | Times Cited: 13
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin, et al.
Seminars in Cancer Biology (2023) Vol. 98, pp. 31-50
Closed Access | Times Cited: 13
Isoorientin: Unveiling the hidden flavonoid's promise in combating cancer development and progression – A comprehensive review
Lucas Fornari Laurindo, Karina Torres Pomini, Enzo Pereira de Lima, et al.
Life Sciences (2024), pp. 123280-123280
Open Access | Times Cited: 5
Lucas Fornari Laurindo, Karina Torres Pomini, Enzo Pereira de Lima, et al.
Life Sciences (2024), pp. 123280-123280
Open Access | Times Cited: 5
RNA-binding proteins as versatile metabolic regulators
Ellie Koletsou, Ina Huppertz
npj Metabolic Health and Disease (2025) Vol. 3, Iss. 1
Open Access
Ellie Koletsou, Ina Huppertz
npj Metabolic Health and Disease (2025) Vol. 3, Iss. 1
Open Access
Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging
Hui Fang, Eunsun Yu, Chang Liu, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 1-15
Closed Access
Hui Fang, Eunsun Yu, Chang Liu, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 1-15
Closed Access
circ0066187 promotes pulmonary fibrogenesis through targeting STAT3-mediated metabolism signal pathway
Bo Liu, Weili Liu, Hongbo Li, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Bo Liu, Weili Liu, Hongbo Li, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Metabolism in stem cell driven leukaemia: parallels between haematopoiesis and immunity
Kevin M. Rattigan, Martha M. Zarou, G. Vignir Helgason
Blood (2023)
Open Access | Times Cited: 9
Kevin M. Rattigan, Martha M. Zarou, G. Vignir Helgason
Blood (2023)
Open Access | Times Cited: 9
The role of cancer cell bioenergetics in dormancy and drug resistance
Steven Tau, Todd W. Miller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 87-98
Closed Access | Times Cited: 9
Steven Tau, Todd W. Miller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 87-98
Closed Access | Times Cited: 9
LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling
Fufeng Gao, Jinlong Chen, Tingting Zhang, et al.
Experimental Cell Research (2022) Vol. 421, Iss. 1, pp. 113360-113360
Closed Access | Times Cited: 14
Fufeng Gao, Jinlong Chen, Tingting Zhang, et al.
Experimental Cell Research (2022) Vol. 421, Iss. 1, pp. 113360-113360
Closed Access | Times Cited: 14
Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance
Layla Simón, Sofía Sanhueza, Belén Gaete‐Ramírez, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Layla Simón, Sofía Sanhueza, Belén Gaete‐Ramírez, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia
Nittaya Limsuwanachot, Budsaba Rerkamnuaychoke, Pimjai Niparuck, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2023) Vol. 28, pp. 122-132
Open Access | Times Cited: 5
Nittaya Limsuwanachot, Budsaba Rerkamnuaychoke, Pimjai Niparuck, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2023) Vol. 28, pp. 122-132
Open Access | Times Cited: 5
8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells
Pei‐Shan Wu, Chih‐Yang Wang, Pin-Shern Chen, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1907-1907
Open Access | Times Cited: 11
Pei‐Shan Wu, Chih‐Yang Wang, Pin-Shern Chen, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1907-1907
Open Access | Times Cited: 11
Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190BCR-ABL
Run Qin, Teng Wang, Wei He, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Run Qin, Teng Wang, Wei He, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects
Meher B. Gayatri, Rama Krishna Kancha, Abhayananda Behera, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Meher B. Gayatri, Rama Krishna Kancha, Abhayananda Behera, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Metabolic Changes during In Vivo Maturation of PSC-Derived Skeletal Myogenic Progenitors
Phablo Abreu, Bayardo I. Garay, Travis Nemkov, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 76-76
Open Access | Times Cited: 4
Phablo Abreu, Bayardo I. Garay, Travis Nemkov, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 76-76
Open Access | Times Cited: 4
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation
Barbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Barbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Respiratory Virus-Induced PARP1 Alters DC Metabolism and Antiviral Immunity Inducing Pulmonary Immunopathology
Mohamed Mire, Srikanth Elesela, Susan Morris, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 910-910
Open Access | Times Cited: 1
Mohamed Mire, Srikanth Elesela, Susan Morris, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 910-910
Open Access | Times Cited: 1
Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells
Sweta B. Patel, Valeriya Kuznetsova, Victoria Matkins, et al.
Experimental Hematology (2022) Vol. 115, pp. 1-13
Closed Access | Times Cited: 7
Sweta B. Patel, Valeriya Kuznetsova, Victoria Matkins, et al.
Experimental Hematology (2022) Vol. 115, pp. 1-13
Closed Access | Times Cited: 7
Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
Mohammad Houshmand, Alireza Kazemi, Ali Anjam-Najmedini, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5805-5805
Open Access | Times Cited: 9
Mohammad Houshmand, Alireza Kazemi, Ali Anjam-Najmedini, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5805-5805
Open Access | Times Cited: 9
Deciphering Metabolic Adaptability of Leukemic Stem Cells
Sweta B. Patel, Travis Nemkov, Angelo D’Alessandro, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Sweta B. Patel, Travis Nemkov, Angelo D’Alessandro, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
Xingjian Zhai, Xiaoyan Jiang
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1841-1841
Open Access | Times Cited: 4
Xingjian Zhai, Xiaoyan Jiang
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1841-1841
Open Access | Times Cited: 4